These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2208701)

  • 1. Triglyceride measurements: a review of methods and interferences.
    Klotzsch SG; McNamara JR
    Clin Chem; 1990 Sep; 36(9):1605-13. PubMed ID: 2208701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of current National Cholesterol Education Program guidelines for total cholesterol triglyceride, HDL-cholesterol, and LDL-cholesterol measurements.
    Caudill SP; Cooper GR; Smith SJ; Myers GL
    Clin Chem; 1998 Aug; 44(8 Pt 1):1650-8. PubMed ID: 9702951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory measurement of lipid and lipoprotein risk factors.
    Warnick GR
    Scand J Clin Lab Invest Suppl; 1990; 198():9-19. PubMed ID: 2189213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement.
    Stein EA; Myers GL
    Clin Chem; 1995 Oct; 41(10):1421-6. PubMed ID: 7586511
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional interlaboratory standardization of determinations of cholesterol, high-density lipoprotein cholesterol, and triglycerides.
    Tetrault GA; Miller WG; Chinchilli VM
    Clin Chem; 1990 Jan; 36(1):145-9. PubMed ID: 2297908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of lipid measurements: relevance for the clinician.
    Schectman G; Sasse E
    Clin Chem; 1993 Jul; 39(7):1495-503. PubMed ID: 8330411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods.
    Beheshti I; Wessels LM; Eckfeldt JH
    Clin Chem; 1994 Nov; 40(11 Pt 1):2088-92. PubMed ID: 7955384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of predispensed reagent and noncentrifugation methods for high-density lipoprotein cholesterol measurement.
    Zhang DJ; LaRue S; Miller WG; Cole TG
    Arch Pathol Lab Med; 1997 Sep; 121(9):938-47. PubMed ID: 9302925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride measurement and its relationship to heart disease.
    Stein EA; Steiner PM
    Clin Lab Med; 1989 Mar; 9(1):169-85. PubMed ID: 2647372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.
    Griffin BA; Freeman DJ; Tait GW; Thomson J; Caslake MJ; Packard CJ; Shepherd J
    Atherosclerosis; 1994 Apr; 106(2):241-53. PubMed ID: 8060384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of circulating high-density lipoprotein and triglycerides in coronary artery disease: risk and prevention.
    Gordon DJ
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):299-309. PubMed ID: 2192875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride levels and the risk of coronary artery disease: a view from Australia.
    Simons LA
    Am J Cardiol; 1992 Dec; 70(19):14H-18H. PubMed ID: 1466312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or =4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation.
    Tighe DA; Ockene IS; Reed G; Nicolosi R
    Clin Chim Acta; 2006 Mar; 365(1-2):236-42. PubMed ID: 16259972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement.
    Bachorik PS; Ross JW
    Clin Chem; 1995 Oct; 41(10):1414-20. PubMed ID: 7586510
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of two compact analyzers used for lipid analysis.
    McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
    J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory.
    Warnick GR
    Clin Chem Lab Med; 2000 Apr; 38(4):287-300. PubMed ID: 10928647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system.
    Rapi S; Bazzini C; Tozzetti C; Sbolci V; Modesti PA
    Transl Res; 2009 Feb; 153(2):71-6. PubMed ID: 19138651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.